These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 30630474)

  • 1. Detection of endoplasmic reticulum stress and the unfolded protein response in naturally-occurring endocrinopathic equine laminitis.
    Cassimeris L; Engiles JB; Galantino-Homer H
    BMC Vet Res; 2019 Jan; 15(1):24. PubMed ID: 30630474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of p63, a regulator of epidermal stem cells, in the chronic laminitic equine hoof.
    Carter RA; Engiles JB; Megee SO; Senoo M; Galantino-Homer HL
    Equine Vet J; 2011 Sep; 43(5):543-51. PubMed ID: 21496086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific dysregulation of cortisol metabolism in equine laminitis.
    Johnson PJ; Ganjam VK; Slight SH; Kreeger JM; Messer NT
    Equine Vet J; 2004 Jan; 36(1):41-5. PubMed ID: 14756370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.
    Karikoski NP; McGowan CM; Singer ER; Asplin KE; Tulamo RM; Patterson-Kane JC
    Vet Pathol; 2015 Sep; 52(5):945-56. PubMed ID: 25232034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of endothelin in equine laminitis.
    Katwa LC; Johnson PJ; Ganjam VK; Kreeger JM; Messer NT
    Equine Vet J; 1999 May; 31(3):243-7. PubMed ID: 10402139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte-derived and endogenous matrix metalloproteinases in the lamellae of horses with naturally acquired and experimentally induced laminitis.
    Loftus JP; Johnson PJ; Belknap JK; Pettigrew A; Black SJ
    Vet Immunol Immunopathol; 2009 Jun; 129(3-4):221-30. PubMed ID: 19101039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum markers of lamellar basement membrane degradation and lamellar histopathological changes in horses affected with laminitis.
    Johnson PJ; Kreeger JM; Keeler M; Ganjam VK; Messer NT
    Equine Vet J; 2000 Nov; 32(6):462-8. PubMed ID: 11093618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-17A pathway target genes are upregulated in Equus caballus supporting limb laminitis.
    Cassimeris L; Engiles JB; Galantino-Homer H
    PLoS One; 2020; 15(12):e0232920. PubMed ID: 33301461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation endproducts in horses with insulin-induced laminitis.
    de Laat MA; Kyaw-Tanner MT; Sillence MN; McGowan CM; Pollitt CC
    Vet Immunol Immunopathol; 2012 Jan; 145(1-2):395-401. PubMed ID: 22240145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Equine laminitis: comparative histopathology 48 hours after experimental induction with insulin or alimentary oligofructose in standardbred horses.
    de Laat MA; van Eps AW; McGowan CM; Sillence MN; Pollitt CC
    J Comp Pathol; 2011 Nov; 145(4):399-409. PubMed ID: 21429503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.
    de Laat MA; Sillence MN; Reiche DB
    J Vet Intern Med; 2019 May; 33(3):1456-1463. PubMed ID: 30697823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histopathology of insulin-induced laminitis in ponies.
    Asplin KE; Patterson-Kane JC; Sillence MN; Pollitt CC; Mc Gowan CM
    Equine Vet J; 2010 Nov; 42(8):700-6. PubMed ID: 21039799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of cellular and molecular mechanisms in endocrinopathic, sepsis-related and supporting limb equine laminitis.
    Elliott J; Bailey SR
    Equine Vet J; 2023 May; 55(3):350-375. PubMed ID: 36847165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitogen-activated kinase pathway activation in epidermal lamellae in the acute stages of carbohydrate overload laminitis models and the effect of regional deep hypothermia on signalling pathways.
    Gardner AK; Kelly CS; van Eps AW; Burns TA; Watts MR; Belknap JK
    Equine Vet J; 2016 Sep; 48(5):633-40. PubMed ID: 26222495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopathology in the Equine Distal Phalanx Associated With the Development and Progression of Laminitis.
    Engiles JB; Galantino-Homer HL; Boston R; McDonald D; Dishowitz M; Hankenson KD
    Vet Pathol; 2015 Sep; 52(5):928-44. PubMed ID: 26063172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic profile distinguishes laminitis-susceptible and -resistant ponies before and after feeding a high sugar diet.
    Delarocque J; Reiche DB; Meier AD; Warnken T; Feige K; Sillence MN
    BMC Vet Res; 2021 Jan; 17(1):56. PubMed ID: 33509165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression in the lamellar dermis-epidermis during the developmental phase of carbohydrate overload-induced laminitis in the horse.
    Budak MT; Orsini JA; Pollitt CC; Rubinstein NA
    Vet Immunol Immunopathol; 2009 Sep; 131(1-2):86-96. PubMed ID: 19380162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic equine laminitis is characterised by loss of GLUT1, GLUT4 and ENaC positive laminar keratinocytes.
    Mobasheri A; Critchlow K; Clegg PD; Carter SD; Canessa CM
    Equine Vet J; 2004 Apr; 36(3):248-54. PubMed ID: 15147133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of purinergic P2X receptor subtypes 1, 2, 3 and 7 in equine laminitis.
    Zamboulis DE; Senior M; Clegg PD; Milner PI
    Vet J; 2013 Nov; 198(2):472-8. PubMed ID: 24080476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis.
    de Laat MA; Pollitt CC; Kyaw-Tanner MT; McGowan CM; Sillence MN
    Vet J; 2013 Aug; 197(2):302-6. PubMed ID: 23394844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.